Fresh science and technology news from Iraq

Provided by AGP

Tech News Iraq: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News Iraq.

Press releases published on May 7, 2026

AvePoint Announces First Quarter 2026 Financial Results
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
CarGurus Announces First Quarter 2026 Results
Definitive Healthcare Reports Financial Results for First Quarter 2026
 Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
EverCommerce Announces First Quarter 2026 Financial Results
Atsena Presents Positive Clinical Data from Its XLRS and LCA1 Gene Therapy Programs at ARVO 2026
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
Silvaco Reports First Quarter 2026 Financial Results
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
Red Cat Reports Q1 2026; Q1 Revenue Growth of 849% Y/Y; Q1 Gross Margins Increase of 64.8 Percent Points Y/Y; Gross Margins Increase 199% Sequentially From Q4 2025
Cerence AI Delivers Strong Q2 FY26 Results with Revenue Above Guidance; Raises and Refines Full-Year Outlook
LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update
Codexis Reports First Quarter 2026 Financial Results
TTEC Announces First Quarter 2026 Financial Results and Reiterates Outlook for Full Year 2026
Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results
Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
PacBio Announces First Quarter 2026 Financial Results

Share us

on your social networks:

Sign up for:

Tech News Iraq

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.